Marc L. Hilhorst - Publications

Extended-Release Tacrolimus Versus LifeCycle Pharma Tacrolimus in Kidney Transplant Recipients: A Switch Study.

Journal: Therapeutic drug monitoring

Published: April 14, 2026

Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled Trial.

Journal: Journal of the American Society of Nephrology : JASN

Published: September 29, 2025

Collapsing FSGS in a kidney transplant with a single APOL1 risk variant: a case report.

Journal: BMC nephrology

Published: September 17, 2025

Purinoreceptor P2X7 in Extracellular ATP-Mediated Inflammation through the Spectrum of Kidney Diseases and Kidney Transplantation.

Journal: Journal of the American Society of Nephrology : JASN

Published: March 28, 2025

Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.

Journal: The Journal of dermatology

Published: October 24, 2024

Infiltrative classical monocyte-derived and SPP1 lipid-associated macrophages mediate inflammation and fibrosis in ANCA-associated glomerulonephritis.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: April 09, 2024

Cardiovascular risk in ANCA-associated vasculitis: Monocyte phenotyping reveals distinctive signatures between serological subsets.

Journal: Atherosclerosis

Published: January 25, 2024

Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.

Journal: The Journal of allergy and clinical immunology

Published: December 23, 2023

Not Everything Is as It Seems: A Case Series and Overview of Diseases Mimicking Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Journal: Journal of clinical medicine

Published: September 03, 2023

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.

Journal: BMC infectious diseases

Published: November 15, 2022

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.

Journal: Journal of autoimmunity

Published: October 24, 2022

Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases.

Journal: Annals of the rheumatic diseases

Published: October 12, 2022